Background: Shingles causes considerable morbidity in older persons. Zostavax, a vaccine against shingles, reduces the incidence of shingles by 50% and the burden of illness by two-thirds. Little is known about the factors that contribute to the patient's intention to get Zostavax. Methods & Materials: A two stage simple random sampling process was undertaken to identify a random sample of GPs across two urban areas in South Australia to identify the key beliefs about shingles and its complications and the factors that may influence the uptake of the Zostavax.
|Number of pages||2|
|Journal||International Journal of Infectious Diseases|
|Issue number||Supplement 1|
|Publication status||Published - Apr 2014|
|Event||16th International Congress on Infectious Diseases - Cape Town, South Africa|
Duration: 2 Apr 2014 → 5 Apr 2014
Conference number: 16
Bibliographical noteThis article is available under the Creative Commons CC-BY-NC-ND license and permits non-commercial use of the work as published, without adaptation or alteration provided the work is fully attributed.
- older adults
- older persons
Litt, J., Kim, S., Woodman, R., MacIntyre, R., & Cunningham, T. (2014). Australian zoster study: GP and patient views about herpes zoster (shingles), its complications, and the likely acceptance of a zoster vaccine. International Journal of Infectious Diseases, 21(Supplement 1), 436-437. https://doi.org/10.1016/j.ijid.2014.03.1320